UW Spinout Bellwether Bio Raises $2.7M Seed to Commercialize Non‑Invasive Liquid Biopsy Founded by Jay Shendure and Matthew Snyder

Bellwether Bio, a University of Washington spinout founded by genomics researcher Jay Shendure and technologist Matthew Snyder, is commercializing a non-invasive liquid biopsy that analyzes tumor DNA in blood and raised an oversubscribed seed round totaling $2.7 million per an SEC filing. Investors include the UW’s W Fund, WRF Capital and Bioeconomy Capital, and the company says it is collaborating with cancer diagnostics firms to validate and commercialize the technology.

No comments yet.